
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
BlackRock Health Sciences Trust (BME)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: BME (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 2.33% | Avg. Invested days 46 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 468.11M USD | Price to earnings Ratio 22.22 | 1Y Target Price - |
Price to earnings Ratio 22.22 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.63 | 52 Weeks Range 33.44 - 39.99 | Updated Date 06/29/2025 |
52 Weeks Range 33.44 - 39.99 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 8.68% | Basic EPS (TTM) 1.63 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 309.96% | Operating Margin (TTM) 1.96% |
Management Effectiveness
Return on Assets (TTM) 0.1% | Return on Equity (TTM) 4.14% |
Valuation
Trailing PE 22.22 | Forward PE - | Enterprise Value 480385856 | Price to Sales(TTM) 61.86 |
Enterprise Value 480385856 | Price to Sales(TTM) 61.86 | ||
Enterprise Value to Revenue 19.45 | Enterprise Value to EBITDA - | Shares Outstanding 12924100 | Shares Floating - |
Shares Outstanding 12924100 | Shares Floating - | ||
Percent Insiders - | Percent Institutions 21.79 |
Upturn AI SWOT
BlackRock Health Sciences Trust
Company Overview
History and Background
BlackRock Health Sciences Trust (BME) is a closed-end equity fund. It was incepted on October 29, 2005. It invests in companies engaged in the health sciences and related industries.
Core Business Areas
- Equity Investments: The fund primarily invests in equity securities of companies in the health sciences and related industries, including pharmaceutical, biotechnology, medical technology, and healthcare services companies.
Leadership and Structure
BME is managed by BlackRock Advisors, LLC. BlackRock is a global investment management firm, and its leadership team consists of seasoned professionals with expertise in investment management, portfolio construction, and risk management. The fund's portfolio managers are responsible for making investment decisions based on their analysis of market trends and company fundamentals.
Top Products and Market Share
Key Offerings
- Closed-End Fund: BME is a closed-end fund, meaning it issues a fixed number of shares that trade on the stock exchange. Its focus is solely on investment within the health science industry. Competitors include Tekla Healthcare Opportunities Fund (THQ), Columbia Seligman Premium Tech Growth Fund (STK) and Eaton Vance Healthcare Fund (ETV).
Market Dynamics
Industry Overview
The health sciences industry is characterized by innovation, regulation, and demographic shifts. It's a sector with high growth potential due to aging populations and advancements in medical technology.
Positioning
BME is positioned as an investment vehicle for investors seeking exposure to the growth potential of the health sciences industry through a diversified portfolio of companies.
Total Addressable Market (TAM)
The global healthcare market is estimated to be in the trillions of dollars. BME is positioned to capture a portion of this market by investing in companies across various sub-sectors within the health sciences industry.
Upturn SWOT Analysis
Strengths
- Experienced management team
- Diversified portfolio within the health sciences sector
- Access to BlackRock's global research resources
Weaknesses
- Closed-end fund structure can lead to trading at a discount to NAV
- Subject to market volatility
- Management fees can impact returns
Opportunities
- Growth in emerging markets healthcare
- Advancements in medical technology and biotechnology
- Increasing demand for healthcare services due to aging populations
Threats
- Regulatory changes in the healthcare industry
- Economic downturns affecting healthcare spending
- Competition from other investment vehicles
Competitors and Market Share
Key Competitors
- THQ
- STK
- ETV
Competitive Landscape
BME's advantages include BlackRock's brand and research capabilities. Disadvantages could include higher management fees or underperformance compared to peers.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends would be evaluated based on the fund's performance over the past several years.
Future Projections: Future growth projections would rely on analyst estimates and market forecasts for the health sciences industry.
Recent Initiatives: Recent strategic initiatives would include any changes in the fund's investment strategy or portfolio composition.
Summary
BlackRock Health Sciences Trust offers investors access to the health sciences sector through a managed portfolio. The fund's performance is influenced by industry dynamics and market conditions. BME benefits from BlackRock's expertise but faces competition and market risks. Monitoring its NAV, distributions, and competitive positioning is crucial. While it has strengths in management and access to resources, it is crucial to be mindful of the volatility within the stock market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- BlackRock official website
- Financial data providers (e.g., Bloomberg, Reuters)
- Analyst reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Market conditions and fund performance can change. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About BlackRock Health Sciences Trust
Exchange NYSE | Headquaters New York, NY, United States | ||
IPO Launch date 2005-03-29 | CEO - | ||
Sector Financial Services | Industry Asset Management | Full time employees - | |
Full time employees - |
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.